Stroma cells promote a S100A8/A9(high) subset of chemoresistant AML blasts with distinct metabolic features in a Jak/STAT-dependent manner

Böttcher M, Panagiotidis K, Mentz K, Popp S, Geyh S, Jaeger P, Schroeder T, Bruns H, Mackensen A, Mougiakakos D, Völkl S (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 41-42

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Martin Böttcher Department of Medicine 5 – Haematology and Oncology Konstantinos Panagiotidis Department of Medicine 5 – Haematology and Oncology Sebastian Popp Lehrstuhl für Neurologie Heiko Bruns Department of Medicine 5 – Haematology and Oncology Andreas Mackensen Lehrstuhl für Innere Medizin V Dimitrios Mougiakakos Professur für Hämatologie/Onkologie mit dem Schwerpunkt Tumorimmunologie Simon Völkl Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Universitätsklinikum Düsseldorf DE Germany (DE)

How to cite

APA:

Böttcher, M., Panagiotidis, K., Mentz, K., Popp, S., Geyh, S., Jaeger, P.,... Völkl, S. (2020). Stroma cells promote a S100A8/A9(high) subset of chemoresistant AML blasts with distinct metabolic features in a Jak/STAT-dependent manner. In ONCOLOGY RESEARCH AND TREATMENT (pp. 41-42). BASEL: KARGER.

MLA:

Böttcher, Martin, et al. "Stroma cells promote a S100A8/A9(high) subset of chemoresistant AML blasts with distinct metabolic features in a Jak/STAT-dependent manner." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2020. 41-42.

BibTeX: Download